Transitional cell carcinoma laboratory findings

Transitional cell carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Transitional cell carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Cystoscopy and Bladder Biopsy
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Transitional cell carcinoma laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Transitional cell carcinoma laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Transitional cell carcinoma laboratory findings
CDC on Transitional cell carcinoma laboratory findings
Transitional cell carcinoma laboratory findings in the news
Blogs on Transitional cell carcinoma laboratory findings
Directions to Hospitals Treating Transitional cell carcinoma
Risk calculators and risk factors for Transitional cell carcinoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

• Urinalysis

• Blood in the urine

• Urine cytology

• Abnormal cells in the urine

• Tumor marker tests

• Bladder tumor–associated antigen (BTA)
• Nuclear matrix proteins (NMP)
• Mucin and carcinoembryonic antigen (CEA)

• Complete blood count

• Low red blood cell count

• Blood chemistry tests

• Elevated alkaline phosphatase